• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤利什曼病的临床多样性和治疗结果:459 例欧洲临床报告。

Clinical diversity and treatment results in Tegumentary Leishmaniasis: A European clinical report in 459 patients.

机构信息

Necker-Pasteur Infectiology Centre, Necker-Enfants Malades University Hospital, Institut Imagine, Assistance Publique-Hôpitaux de Paris, Paris, France.

Confluent Private Hospital, Nantes, France.

出版信息

PLoS Negl Trop Dis. 2021 Oct 13;15(10):e0009863. doi: 10.1371/journal.pntd.0009863. eCollection 2021 Oct.

DOI:10.1371/journal.pntd.0009863
PMID:
34644288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8544871/
Abstract

BACKGROUND

Cutaneous leishmaniasis (CL) is frequent in travellers and can involve oro-nasal mucosae. Clinical presentation impacts therapeutic management.

METHODOLOGY

Demographic and clinical data from 459 travellers infected in 47 different countries were collected by members of the European LeishMan consortium. The infecting Leishmania species was identified in 198 patients.

PRINCIPAL FINDINGS

Compared to Old World CL, New World CL was more frequently ulcerative (75% vs 47%), larger (3 vs 2cm), less frequently facial (17% vs 38%) and less frequently associated with mucosal involvement (2.7% vs 5.3%). Patients with mucosal lesions were older (58 vs 30 years) and more frequently immunocompromised (37% vs 3.5%) compared to patients with only skin lesions. Young adults infected in Latin America with L. braziliensis or L. guyanensis complex typically had an ulcer of the lower limbs with mucosal involvement in 5.8% of cases. Typically, infections with L. major and L. tropica acquired in Africa or the Middle East were not associated with mucosal lesions, while infections with L. infantum, acquired in Southern Europe resulted in slowly evolving facial lesions with mucosal involvement in 22% of cases. Local or systemic treatments were used in patients with different clinical presentations but resulted in similarly high cure rates (89% vs 86%).

CONCLUSION/SIGNIFICANCE: CL acquired in L. infantum-endemic European and Mediterranean areas displays unexpected high rates of mucosal involvement comparable to those of CL acquired in Latin America, especially in immunocompromised patients. When used as per recommendations, local therapy is associated with high cure rates.

摘要

背景

皮肤利什曼病(CL)在旅行者中很常见,可累及口腔和鼻腔黏膜。临床表现影响治疗管理。

方法

欧洲利什曼虫病联盟成员收集了来自 47 个不同国家的 459 名旅行者的人口统计学和临床数据。在 198 名患者中鉴定了感染的利什曼原虫种。

主要发现

与旧世界 CL 相比,新世界 CL 更常为溃疡性(75% vs 47%)、更大(3 厘米 vs 2 厘米)、较少发生于面部(17% vs 38%)、较少发生黏膜受累(2.7% vs 5.3%)。有黏膜病变的患者年龄较大(58 岁 vs 30 岁)且免疫功能受损的情况更常见(37% vs 3.5%)。与仅有皮肤病变的患者相比,在拉丁美洲感染 L. braziliensis 或 L. guyanensis 复合物的年轻成年人下肢溃疡有 5.8%的情况下伴有黏膜受累。通常,在非洲或中东感染的 L. major 和 L. tropica 不伴有黏膜病变,而在南欧感染的 L. infantum 则导致黏膜受累的面部病变缓慢进展,在 22%的病例中出现这种情况。不同临床表现的患者使用局部或全身治疗,但治愈率相似(89% vs 86%)。

结论/意义:在 L. infantum 流行的欧洲和地中海地区获得的 CL 显示出出人意料的高黏膜受累率,与在拉丁美洲获得的 CL 相当,尤其是在免疫功能受损的患者中。当按照建议使用时,局部治疗与高治愈率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111f/8544871/66cce28497f9/pntd.0009863.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111f/8544871/e96fb2e573ef/pntd.0009863.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111f/8544871/2a9a93f76e2d/pntd.0009863.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111f/8544871/66cce28497f9/pntd.0009863.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111f/8544871/e96fb2e573ef/pntd.0009863.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111f/8544871/2a9a93f76e2d/pntd.0009863.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/111f/8544871/66cce28497f9/pntd.0009863.g003.jpg

相似文献

1
Clinical diversity and treatment results in Tegumentary Leishmaniasis: A European clinical report in 459 patients.皮肤利什曼病的临床多样性和治疗结果:459 例欧洲临床报告。
PLoS Negl Trop Dis. 2021 Oct 13;15(10):e0009863. doi: 10.1371/journal.pntd.0009863. eCollection 2021 Oct.
2
Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.脂质体两性霉素B治疗皮肤和黏膜皮肤利什曼病旅行者:并非万灵药。
PLoS Negl Trop Dis. 2017 Nov 20;11(11):e0006094. doi: 10.1371/journal.pntd.0006094. eCollection 2017 Nov.
3
New epidemiological pattern of cutaneous leishmaniasis in two pre-Saharan arid provinces, southern Morocco.摩洛哥南部撒哈拉沙漠前两个干旱省份皮肤利什曼病的新流行模式。
Acta Trop. 2017 Sep;173:11-16. doi: 10.1016/j.actatropica.2017.05.016. Epub 2017 May 17.
4
Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment.瑞士的皮肤利什曼病:针对特定物种治疗的首次经验。
Infection. 2013 Dec;41(6):1177-82. doi: 10.1007/s15010-013-0500-5. Epub 2013 Jul 9.
5
Changes in the microbiological diagnosis and epidemiology of cutaneous leishmaniasis in real-time PCR era: A six-year experience in a referral center in Barcelona.实时聚合酶链反应时代皮肤利什曼病的微生物学诊断和流行病学变化:巴塞罗那一家转诊中心的六年经验。
PLoS Negl Trop Dis. 2021 Nov 10;15(11):e0009884. doi: 10.1371/journal.pntd.0009884. eCollection 2021 Nov.
6
Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.利什曼原虫(维安亚属)种类对美洲皮肤利什曼病患者抗锑治疗反应的影响。
J Infect Dis. 2007 Jun 15;195(12):1846-51. doi: 10.1086/518041. Epub 2007 May 3.
7
Re-emergence of visceral and cutaneous leishmaniasis in the Greek Island of Crete.克里特岛再现内脏利什曼病和皮肤利什曼病。
Vector Borne Zoonotic Dis. 2012 Mar;12(3):214-22. doi: 10.1089/vbz.2011.0004. Epub 2012 Jan 4.
8
Monitoring the response of patients with cutaneous leishmaniasis to treatment with pentamidine isethionate by quantitative real-time PCR, and identification of Leishmania parasites not responding to therapy.通过定量实时聚合酶链反应监测皮肤利什曼病患者对乙磺酸盐喷他脒治疗的反应,并鉴定对治疗无反应的利什曼原虫寄生虫。
Clin Exp Dermatol. 2016 Aug;41(6):610-5. doi: 10.1111/ced.12786. Epub 2015 Dec 9.
9
DNA-based detection of and species isolated from humans in cutaneous and post-kala-azar dermal leishmaniasis from Shiraz and Kharameh, southern Iran.从伊朗南部设拉子和哈拉梅的皮肤和黑热病后皮肤利什曼病患者中分离出的 和 种的基于 DNA 的检测。
J Vector Borne Dis. 2020 Jan-Mar;57(1):52-57. doi: 10.4103/0972-9062.309518.
10
American Cutaneous Leishmaniasis: Imported cases in Berlin 2000-2023.美国皮肤利什曼病:2000-2023 年柏林的输入性病例。
PLoS Negl Trop Dis. 2024 Jul 15;18(7):e0012323. doi: 10.1371/journal.pntd.0012323. eCollection 2024 Jul.

引用本文的文献

1
A comprehensive phenotypic and genotypic taxonomic review of Leishmania (Leishmania) poncei n. sp. (Kinetoplastea: Trypanosomatidae): a novel agent of cutaneous (non-ulcerated) and visceral leishmaniasis in Honduras, Central America.庞氏利什曼原虫(利什曼原虫属)新种的全面表型和基因型分类学综述:中美洲洪都拉斯皮肤(非溃疡性)和内脏利什曼病的一种新病原体(动基体目:锥虫科)
Trop Dis Travel Med Vaccines. 2025 Jul 28;11(1):27. doi: 10.1186/s40794-025-00264-1.
2
Molecular Assays on Cutaneous Swabs as an Effective, Non-Invasive Diagnostic Technique for Cutaneous Leishmaniasis: Results from a Retrospective Study Conducted in Italy.皮肤拭子分子检测作为皮肤利什曼病的一种有效、非侵入性诊断技术:意大利一项回顾性研究的结果
Trop Med Infect Dis. 2025 Jun 9;10(6):158. doi: 10.3390/tropicalmed10060158.
3

本文引用的文献

1
Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis.旅行者和移民中的皮肤和黏膜利什曼病:20 年 GeoSentinel 监测网络分析。
J Travel Med. 2019 Dec 23;26(8). doi: 10.1093/jtm/taz055.
2
Topical paromomycin for New World cutaneous leishmaniasis.局部用巴龙霉素治疗新热带皮肤利什曼病。
PLoS Negl Trop Dis. 2019 May 2;13(5):e0007253. doi: 10.1371/journal.pntd.0007253. eCollection 2019 May.
3
Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel.
Cutaneous leishmaniasis in Afghanistan.阿富汗的皮肤利什曼病
Trans R Soc Trop Med Hyg. 2025 Aug 8;119(8):848-864. doi: 10.1093/trstmh/traf028.
4
A rare case of lingual mucosal leishmaniasis caused by reactivation of Leishmania infantum infection.一例由婴儿利什曼原虫感染复发引起的罕见舌黏膜利什曼病病例。
BMC Infect Dis. 2025 Feb 18;25(1):234. doi: 10.1186/s12879-025-10592-4.
5
Mucosal Leishmaniasis in Tunisia: Observations from a Rare Case Report.突尼斯的黏膜利什曼病:一例罕见病例报告的观察结果
Am J Trop Med Hyg. 2025 Feb 18;112(5):966-969. doi: 10.4269/ajtmh.24-0592. Print 2025 May 7.
6
Cutaneous leishmaniasis in sub-Saharan Africa: a systematic review of Leishmania species, vectors and reservoirs.撒哈拉以南非洲的皮肤利什曼病:利什曼原虫种类、传播媒介和宿主的系统评价
Parasit Vectors. 2024 Jul 24;17(1):318. doi: 10.1186/s13071-024-06381-8.
7
American Cutaneous Leishmaniasis: Imported cases in Berlin 2000-2023.美国皮肤利什曼病:2000-2023 年柏林的输入性病例。
PLoS Negl Trop Dis. 2024 Jul 15;18(7):e0012323. doi: 10.1371/journal.pntd.0012323. eCollection 2024 Jul.
8
Isolation and characterisation of Leishmania (Leishmania) infantum from cutaneous leishmaniasis patients in northeast Brazil.从巴西东北部皮肤利什曼病患者中分离和鉴定利什曼原虫(利什曼原虫)。
Mem Inst Oswaldo Cruz. 2024 Jul 8;119:e240026. doi: 10.1590/0074-02760240026. eCollection 2024.
9
Leishmaniasis in otorhinolaryngology: an emerging disease and its relationship with anti-tumor necrosis factor-alpha drugs.耳鼻喉科利什曼病:一种新兴疾病及其与抗肿瘤坏死因子-α药物的关系。
Eur Arch Otorhinolaryngol. 2024 May;281(5):2739-2742. doi: 10.1007/s00405-024-08569-1. Epub 2024 Mar 8.
10
Molecular Typing of spp. Causing Tegumentary Leishmaniasis in Northeastern Italy, 2014-2020.2014 - 2020年意大利东北部引起皮肤利什曼病的 种的分子分型
Pathogens. 2023 Dec 24;13(1):19. doi: 10.3390/pathogens13010019.
旅行者感染巴西利什曼原虫复合体返回以色列后的黏膜利什曼病。
Emerg Infect Dis. 2019 Apr;25(4):642-648. doi: 10.3201/eid2504.180239.
4
Topical 15% Paromomycin-Aquaphilic for Bolivian Leishmania braziliensis Cutaneous Leishmaniasis: A Randomized, Placebo-controlled Trial.局部应用 15%巴龙霉素-亲水性凝胶治疗玻利维亚巴西利什曼原虫皮肤利什曼病:一项随机、安慰剂对照试验。
Clin Infect Dis. 2019 Feb 15;68(5):844-849. doi: 10.1093/cid/ciy619.
5
Leishmaniasis.利什曼病。
Lancet. 2018 Sep 15;392(10151):951-970. doi: 10.1016/S0140-6736(18)31204-2. Epub 2018 Aug 17.
6
Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review.脂质体两性霉素B治疗旧世界皮肤和黏膜利什曼病:文献综述
Acta Trop. 2018 Jun;182:246-250. doi: 10.1016/j.actatropica.2018.03.016. Epub 2018 Mar 14.
7
Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.脂质体两性霉素B治疗皮肤和黏膜皮肤利什曼病旅行者:并非万灵药。
PLoS Negl Trop Dis. 2017 Nov 20;11(11):e0006094. doi: 10.1371/journal.pntd.0006094. eCollection 2017 Nov.
8
Case Report: Old World Mucosal Leishmaniasis: Report of Five Imported Cases to the Hospital for Tropical Diseases, London, United Kingdom.病例报告:旧世界黏膜利什曼病:英国伦敦热带病医院5例输入性病例报告
Am J Trop Med Hyg. 2017 Oct;97(4):1116-1119. doi: 10.4269/ajtmh.17-0162.
9
Global burden of cutaneous leishmaniasis.皮肤利什曼病的全球负担。
Lancet Infect Dis. 2017 Mar;17(3):264. doi: 10.1016/S1473-3099(16)30217-1. Epub 2017 Feb 23.
10
Leishmania infections: Molecular targets and diagnosis.利什曼原虫感染:分子靶标与诊断。
Mol Aspects Med. 2017 Oct;57:1-29. doi: 10.1016/j.mam.2016.11.012. Epub 2017 Jan 31.